AzTrials
AzTrials

Suicide PreventionSUNDANCENCT03136094

Suicide in Urban Natives: Detection and Networks to Combat Events

A study testing SBIRT+12 in people with Suicide Prevention, run by University of Colorado, Denver at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study compares the effectiveness of a program to detect and manage suicide risk among American-Indian and Alaska Native (AI/AN) youth. Half of the participants will receive caring text messages to reduce suicidal thoughts, attempts, and hospitalizations and to increase engagement, social connectedness, and… Read more about this study

Who is it for?
Ages 18 to 34 years
Conditions the study is for
Suicide Prevention
What is being tested?
SBIRT+12
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
698 participants
Where
1 siteUnited States
Study dates
15 Mar 2020to 31 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 34 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Self-identify as American Indian or Alaska Native;
  • Screen positive for mild, moderate, or severe risk of suicidality (referred by a clinical provider);
  • Have a text-enabled mobile phone;
  • Willing to be contacted by text;
  • Able to participate voluntarily;
  • Speak and read English;
  • Cognitively able to independently provide written informed consent

Who cannot join

  • Under age 18
  • In danger of imminent self-harm;
  • Hospitalized

Trial locations and contacts

1 site in 1 country.

United States1 site, 1 recruiting
  • First Nations Community HealthSource

    Albuquerque, New Mexico, 87108

    Nichole Tsosie, MPH, 505-262-2481, nichole.tsosie@fnch.org

    Linda Son Stone, PhD, 505-262-2481, linda.son-stone@fnch.org

    Recruiting

Other trials in United States

About this study

Official title: Collaborative Hub to Reduce the Burden of Suicide Among Urban American Indian and Alaska Native Young Adults

This study compares the effectiveness of a program to detect and manage suicide risk among American-Indian and Alaska Native (AI/AN) youth. Half of the participants will receive caring text messages to reduce suicidal thoughts, attempts, and hospitalizations and to increase engagement, social connectedness, and resilience in at-risk youth. The other half will receive usual care that does not include the caring text messages.

Read the detailed description

The study, "Suicide in Urban Natives: Detection and Networks to Combat Events," builds on Screening, Brief Intervention and Referral to treatment (SBIRT), carried out through the primary care setting, to detect and manage suicide risk. This approach is multilevel, targeting both the healthcare system and the individual, and links screening to existing mobile phone technologies shown to promote resilience and to tap the protective benefits of social connectedness. This Collaborative Hub will conduct a randomized control trial that compares the effectiveness of enhancing these SBIRT programs by sending caring text messages to reduce suicidal ideation, attempts, and hospitalizations, and to increase engagement, social connectedness, and resilience. The Investigators' long-term goal is to disseminate and translate the lessons learned into practical policy, organizational changes, and preventive innovations that optimize patient-centered health outcomes and ultimately reduce or eliminate the dramatic and tragic suicide-related health disparities among urban AI/AN youth and young adults.

Being tested
SBIRT+12, SBIRT+Usual Care
Keywords
American Indian, Alaska Native, Youth and Young Adult, SBIRT
Medical subject headings
Suicide Prevention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SBIRT+12Behavioural

    The standard SBIRT model is augmented by a 12 month period following identification of suicide risk during which participants received caring text messages adapted from empirically-based, effective interventions for suicide prevention among American Indian and Alaska Native young adults.

  • SBIRT+Usual CareBehavioural

    Patients receive usual SBIRT care

Study groups in NCT03136094
Study groupRoleWhat they receive
SBIRT+Usual CarePlacebo comparatorThe control arm of the trial will receive the usual care prescribed in the Screening, Brief Intervention and Referral to Treatment (SBIRT) model.
Receives: Behavioral: SBIRT+Usual Care
SBIRT+12ExperimentalThe standard SBIRT model is augmented by a 12 month period following identification of suicide risk during which participants will receive caring text messages adapted from empirically-based, effective interventions for suicide prevention among American Indian and Alaska Native young adults.
Receives: Behavioral: SBIRT+12

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Suicidal Ideation

    The 15-item Suicidal Ideation Questionnaire Jr. assesses frequency of suicidal thoughts in the past month. Item content ranges from general thoughts of death and wishes that one were dead to specific thoughts of self-injurious behavior. Responses are on a 7-point scale ranging from never to almost daily. Items are summed for a total score (range 0-90).

    Measured: Baseline, 6 months, 12 months

  2. Change in Self-Reported Suicide Attempts

    The investigators will use the interviewer-administered Suicide Attempt and Self-Injury Count to assess the method, intent, treatment received, and lethality for all suicide attempts over the respondent's lifetime.

    Measured: Baseline, 6 months, 12 months

  3. Change in Hospitalizations and Behavioral Health Treatment

    The investigators will assess self-reported hospitalizations over the previous 12 months with a measure of health service use previously applied to AI/ANs. It captures information on inpatient and outpatient medical care, emergency room visits, and use of traditional practices.

    Measured: Baseline, 6 months, 12 months

Secondary outcomes (2)
  1. Change in Social Connectedness

    The investigators will assess social connectedness with the Interpersonal Needs Questionnaire, a validated measure of feelings of connectedness to others and of being a burden on others.

    Measured: Baseline, 6 months, 12 months

  2. SBIRT Retention and Uptake of Referral to Therapy

    Retention will be measured as binary indicators of complete participation in the appropriate level of intervention determined during the initial in-person session with the behavioral therapist before enrollment in the study, and as uptake of therapy services for people who are referred to this level of care. For each participant, we will create a 3-category indicator of retention (full, partial, none).

    Measured: 6 months, 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 May 2017
  2. Study start15 Mar 2020
  3. Primary completion31 May 2025 (estimated)
  4. Study completion31 May 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
The Investigators will conduct a randomized controlled trial to test the effectiveness of an augmented Screening, Brief Intervention, and Referral to Treatment (SBIRT) model that includes sending caring text messages for 12 months after an at-risk patient is identified.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
698 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03136094
Sponsor's protocol ID
18-0186
Other IDs
U19MH113135
Acronym
SUNDANCE
Status last verified
Jun 2024
First submitted
27 Apr 2017
Last updated
27 Jun 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Herne MA, Bartholomew ML, Weahkee RL. Suicide mortality among American Indians and Alaska Natives, 1999-2009. Am J Public Health. 2014 Jun;104 Suppl 3(Suppl 3):S336-42. doi: 10.2105/AJPH.2014.301929. Epub 2014 Apr 22.

    PubMed 24754665
  • Mann JJ, Apter A, Bertolote J, Beautrais A, Currier D, Haas A, Hegerl U, Lonnqvist J, Malone K, Marusic A, Mehlum L, Patton G, Phillips M, Rutz W, Rihmer Z, Schmidtke A, Shaffer D, Silverman M, Takahashi Y, Varnik A, Wasserman D, Yip P, Hendin H. Suicide prevention strategies: a systematic review. JAMA. 2005 Oct 26;294(16):2064-74. doi: 10.1001/jama.294.16.2064.

    PubMed 16249421
  • Luoma JB, Martin CE, Pearson JL. Contact with mental health and primary care providers before suicide: a review of the evidence. Am J Psychiatry. 2002 Jun;159(6):909-16. doi: 10.1176/appi.ajp.159.6.909.

    PubMed 12042175
  • Beals J, Novins DK, Whitesell NR, Spicer P, Mitchell CM, Manson SM. Prevalence of mental disorders and utilization of mental health services in two American Indian reservation populations: mental health disparities in a national context. Am J Psychiatry. 2005 Sep;162(9):1723-32. doi: 10.1176/appi.ajp.162.9.1723.

    PubMed 16135633
  • Morgan ER, Bogic M, Hebert L, Poole E, Tsosie N, Tsosie N, Garcia K, O'Leary M, Mettler R, Johnson G, Son-Stone L, Parker T, Buchwald D, Manson S. Caring Text Messages for Suicide Prevention in Urban American Indian Youth: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2025 Sep 26;14:e71344. doi: 10.2196/71344.

    PubMed 41004795

Questions about this trial

What is this clinical trial studying?

A study testing SBIRT+12 in people with Suicide Prevention, run by University of Colorado, Denver at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Erin Poole, MS ((303) 724-0177, erin.poole@CUAnschutz.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Suicidal Ideation (time frame: Baseline, 6 months, 12 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03136094, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jun 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in